These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2876405)

  • 41. [Thrombocytopenia in a patient with rheumatoid arthritis during sulphasalazine therapy].
    Keso L; Kaarela K; Oksanen K; Ahonen M
    Duodecim; 1998; 114(17):1731-3. PubMed ID: 11717780
    [No Abstract]   [Full Text] [Related]  

  • 42. [Therapy of juvenile chronic arthritis with sulfasalazine].
    Suschke HJ
    Z Rheumatol; 1987; 46(2):83-5. PubMed ID: 2885990
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neutropenia in patients with rheumatoid arthritis, treated with sulphasalazine.
    Marouf ES; Morris IM
    Br J Rheumatol; 1990 Oct; 29(5):407-9. PubMed ID: 1977490
    [No Abstract]   [Full Text] [Related]  

  • 44. Sulphasalazine: mechanism of action in rheumatoid arthritis.
    Smedegård G; Björk J
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():7-15. PubMed ID: 8535652
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psoriasis-like skin reaction in a patient with rheumatoid arthritis after sulphasalazine therapy.
    Bliddal H; Stangerup M
    Clin Rheumatol; 1991 Jun; 10(2):178-80. PubMed ID: 1680596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does sulphasalazine cause folate deficiency in rheumatoid arthritis?
    Grindulis KA; McConkey B
    Scand J Rheumatol; 1985; 14(3):265-70. PubMed ID: 2864741
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The treatment of rheumatoid polyarthritis using salazosulfapyridine (Salazopyrine). A 6-month open study of 34 patients].
    Ghozlan R; Dupuis M; Schwak A; Jorro P; Lecarpentier C; Guillon C
    Rev Rhum Mal Osteoartic; 1988 Feb; 55(2):127-30. PubMed ID: 2895959
    [No Abstract]   [Full Text] [Related]  

  • 48. Sulphasalazine in arthritis--an old drug rediscovered.
    Taggart AJ
    Clin Rheumatol; 1987 Sep; 6(3):378-83. PubMed ID: 2894913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sulphasalazine-induced systemic lupus erythematosus in a patient with erosive arthritis.
    Walker EM; Carty JE
    Br J Rheumatol; 1994 Feb; 33(2):175-6. PubMed ID: 7909272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A biochemical assessment of sulphasalazine in rheumatoid arthritis.
    Bird HA; Dixon JS; Pickup ME; Rhind VM; Lowe JR; Lee MR; Wright V
    J Rheumatol; 1982; 9(1):36-45. PubMed ID: 6123598
    [No Abstract]   [Full Text] [Related]  

  • 51. [Agranulocytosis in rheumatoid polyarthritis treated with sulfasalazine].
    Pointud P; Cauhape P; Favreau A
    Rev Rhum Mal Osteoartic; 1989 Jun; 56(7):573. PubMed ID: 2569228
    [No Abstract]   [Full Text] [Related]  

  • 52. Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.
    Bax DE; Amos RS
    Ann Rheum Dis; 1985 Mar; 44(3):194-8. PubMed ID: 2858182
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Variables affecting efficacy and toxicity of sulphasalazine in rheumatoid arthritis. A review.
    Pullar T; Capell HA
    Drugs; 1986; 32 Suppl 1():54-7. PubMed ID: 2877854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sulphasalazine induced three-week syndrome.
    Suresh R; Gupta S; Sathananthan R
    J Clin Rheumatol; 2009 Sep; 15(6):311-2. PubMed ID: 19734741
    [No Abstract]   [Full Text] [Related]  

  • 55. Sulphasalazine: a 'new' antirheumatic drug.
    Pullar T; Capell HA
    Br J Rheumatol; 1984 Feb; 23(1):26-34. PubMed ID: 6141832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sulphasalazine induced agranulocytosis in a patient with rheumatoid arthritis.
    Murphy PT; O'Donnell JR
    Ir J Med Sci; 1990 Jun; 159(6):195. PubMed ID: 1977725
    [No Abstract]   [Full Text] [Related]  

  • 57. Sulphasalazine desensitisation in patients with arthritis.
    McCarthy C; Coughlan R
    Ir J Med Sci; 1994 May; 163(5):238-9. PubMed ID: 7913919
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Raised serum alkaline phosphatase and aspartate transaminase levels in two rheumatoid patients treated with sulphasalazine.
    Farr M; Symmons DP; Bacon PA
    Ann Rheum Dis; 1985 Nov; 44(11):798-800. PubMed ID: 2865931
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The clinical efficacy of sulphasalazine in rheumatic disease.
    Taggart AJ
    Agents Actions Suppl; 1988; 24():189-96. PubMed ID: 2903619
    [No Abstract]   [Full Text] [Related]  

  • 60. A double-blind controlled study comparing sulphasalazine with placebo in rheumatoid factor (RF)-negative rheumatoid arthritis.
    Farr M; Waterhouse L; Johnson AE; Kitas GD; Jubb RW; Bacon PA
    Clin Rheumatol; 1995 Sep; 14(5):531-6. PubMed ID: 8549091
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.